Shandong Linuo Pharmaceutical Packaging(SZ:301188) Zheng Quan Zhi Xing·2025-08-21 05:39Summary of Key Points Core Viewpoint - The company, Shandong Linuo Pharmaceutical Packaging Co., Ltd., plans to establish a joint venture with its controlling shareholder, Linuo Group, to utilize idle land resources and leverage Linuo Group's expertise in park construction and management [1][2]. Group 1: Overview of Related Transactions - The joint venture, named Linuo Innovation Technology (Shanghe) Co., Ltd., will be established with Linuo Group holding 51% and the company holding 49% through land contributions valued at approximately RMB 45.41 million [1][4]. - This transaction is classified as a related party transaction due to Linuo Group being the controlling shareholder of the company [2]. - The board of directors approved the investment proposal on August 19, 2025, with independent directors also consenting, thus not requiring shareholder approval [2][8]. Group 2: Financial and Governance Structure - The company will contribute land valued at RMB 45.41 million, while Linuo Group will provide cash for its share [5]. - The governance structure of the joint venture will involve a board elected by shareholders, with the chairman also serving as the general manager [5]. Group 3: Purpose and Impact of the Joint Venture - The primary goal of the joint venture is to revitalize idle land resources and develop a "Science and Technology Innovation Center" [6]. - The collaboration is expected to enhance resource integration and expedite land development, aligning with the company's future growth needs [7]. Group 4: Compliance and Approval Process - The related party transaction has been reviewed and approved by the board and independent directors, adhering to relevant regulations and company policies [8]. - The total amount of related transactions with Linuo Group and its subsidiaries for the year to date is RMB 2.5151 million, excluding this transaction [7].